Phase II of neoadjuvant pembrolizumab and epacadostat in patients with muscle-invasive urothelial bladder cancer: An open label, multicenter, single-arm study
Phase of Trial: Phase II
Latest Information Update: 05 Jun 2018
At a glance
- Drugs Epacadostat (Primary) ; Pembrolizumab (Primary)
- Indications Bladder cancer; Urogenital cancer
- Focus Therapeutic Use
- Acronyms PECULIAR
- 05 Jun 2018 Trial design presented at the 54th Annual Meeting of the American Society of Clinical Oncology.
- 16 Mar 2018 New trial record
- 16 Feb 2018 Trial design presented at the 2018 Genitourinary Cancers Symposium.